Table 1 |
|||
|
Mean number of days of infection (mNDI) and reported versus computed significance levels from Report B [6] |
|||
| First 6 months |
Second 6 months |
All 12 months |
|
|
|
|||
| Placebo Group (n = 19) |
12.7 ± 1.6 |
11.0 ± 1.2 |
23.7 ± 2.3 |
| Supplement Group (n = 22) |
8.5 ± 0.7 |
2.6 ± 0.3 |
11.1 ± 0.8 |
|
|
|||
| Reported p values |
< 0.05 |
< 0.004 |
< 0.02 |
| Computed p values |
|||
| — Assuming "SD" = SD |
< 0.0000000001 |
< 0.00000000000001 |
< 0.00000000000001 |
| — Assuming "SD" = SE |
< 0.012 |
< 0.000001 |
< 0.0001 |
|
|
|||
|
Data are shown as mean ± SD. P values are the reported significance levels for statistical tests of the differences between placebo and supplement groups. |
|||
|
Sternberg and Roberts Nutrition Journal 2006 5:30 doi:10.1186/1475-2891-5-30 |
|||
